Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             120 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute cerebellar ataxia in the Netherlands: A study on the association with vaccinations and varicella zoster infection van der Maas, N.A.T.
2009
27 Supplement 5 p. 1970-1973
4 p.
artikel
2 Adoptive transfer of protective immunity from Cryptosporidium parvum-infected interferon-γ and interleukin-12-deficient mice to naive recipients Tessema, Tesfaye Sisay
2009
27 Supplement 5 p. 6575-6581
7 p.
artikel
3 A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo Thacker, Erin E.
2009
27 Supplement 5 p. 7116-7124
9 p.
artikel
4 A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults Talaat, Kawsar R.
2009
27 Supplement 5 p. 3744-3753
10 p.
artikel
5 Amplified immune response by ginsenoside-based nanoparticles (ginsomes) Song, Xiaoming
2009
27 Supplement 5 p. 2306-2311
6 p.
artikel
6 An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity Khanam, Saima
2009
27 Supplement 5 p. 6011-6021
11 p.
artikel
7 An assessment of the safety of adolescent and adult tetanus–diphtheria–acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink Yih, W. Katherine
2009
27 Supplement 5 p. 4257-4262
6 p.
artikel
8 An economic analysis of rotavirus vaccination in Italy Giammanco, Maria Daniela
2009
27 Supplement 5 p. 3904-3911
8 p.
artikel
9 Antibody kinetics among 8–10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later Gilca, Vladimir
2009
27 Supplement 5 p. 6048-6053
6 p.
artikel
10 Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan Iriemenam, Nnaemeka C.
2009
27 Supplement 5 p. 62-71
10 p.
artikel
11 A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials Boge, Thierry
2009
27 Supplement 5 p. 5677-5684
8 p.
artikel
12 Attitudes towards influenza vaccination of multi-nationality health-care workers in Saudi Arabia Al-Tawfiq, Jaffar A.
2009
27 Supplement 5 p. 5538-5541
4 p.
artikel
13 BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay Eisenhut, Michael
2009
27 Supplement 5 p. 6116-6120
5 p.
artikel
14 Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: Immunogenicity 5 years post-vaccination McIntyre, Peter B.
2009
27 Supplement 5 p. 1062-1066
5 p.
artikel
15 Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy) Panatto, D.
2009
27 Supplement 5 p. 3450-3453
4 p.
artikel
16 Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: Results of a Phase I randomized trial Lyke, Kirsten E.
2009
27 Supplement 5 p. 2171-2176
6 p.
artikel
17 Characterisation of influenza A viruses with mutations in segment 5 packaging signals Hutchinson, Edward C.
2009
27 Supplement 5 p. 6270-6275
6 p.
artikel
18 Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge Platt, Ratree
2009
27 Supplement 5 p. 4508-4519
12 p.
artikel
19 Considerations regarding efficacy endpoints in HIV vaccine trials: Executive summary and recommendations of an expert consultation jointly organized by WHO, UNAIDS and ANRS in support of the Global HIV Vaccine Enterprise Fruth, Uli
2009
27 Supplement 5 p. 1989-1996
8 p.
artikel
20 Control of pertussis—Lessons learnt from a 10-year surveillance programme in Sweden Carlsson, Rose-Marie
2009
27 Supplement 5 p. 5709-5718
10 p.
artikel
21 Cost–benefit comparisons of investments in improved water supply and cholera vaccination programs Jeuland, Marc
2009
27 Supplement 5 p. 3109-3120
12 p.
artikel
22 Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq Weycker, Derek
2009
27 Supplement 5 p. 4930-4937
8 p.
artikel
23 CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague Amemiya, Kei
2009
27 Supplement 5 p. 2220-2229
10 p.
artikel
24 Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam Le, Luan T.
2009
27 Supplement 5 p. F130-F138
nvt p.
artikel
25 Development of a rotavirus vaccine: Clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq® Ciarlet, Max
2009
27 Supplement 5 p. G72-G81
nvt p.
artikel
26 Development of measles vaccines in Japan Ueda, Shigeharu
2009
27 Supplement 5 p. 3230-3231
2 p.
artikel
27 Different effects of probiotic species/strains on infections in preschool children: A double-blind, randomized, controlled study Lin, Jun-Song
2009
27 Supplement 5 p. 1073-1079
7 p.
artikel
28 Does yellow fever 17D vaccine protect against melanoma? Mastrangelo, G.
2009
27 Supplement 5 p. 588-591
4 p.
artikel
29 Economic analysis of pertussis illness in the Dutch population: Implications for current and future vaccination strategies de Greeff, Sabine C.
2009
27 Supplement 5 p. 1932-1937
6 p.
artikel
30 Economic evaluation of a routine rotavirus vaccination programme in Indonesia Wilopo, Siswanto Agus
2009
27 Supplement 5 p. F67-F74
nvt p.
artikel
31 Editorial Board 2009
27 Supplement 5 p. CO2-
1 p.
artikel
32 Editorial Board 2009
27 Supplement 5 p. CO2-
1 p.
artikel
33 Editorial Board 2009
27 Supplement 5 p. CO2-
1 p.
artikel
34 Editorial Board 2009
27 Supplement 5 p. CO2-
1 p.
artikel
35 Editorial Board 2009
27 Supplement 5 p. CO2-
1 p.
artikel
36 Editorial Board 2009
27 Supplement 5 p. CO2-
1 p.
artikel
37 Editorial Board 2009
27 Supplement 5 p. CO2-
1 p.
artikel
38 Editorial Board 2009
27 Supplement 5 p. CO2-
1 p.
artikel
39 Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: A case–control study Joshi, Avni Y.
2009
27 Supplement 5 p. 4457-4461
5 p.
artikel
40 Effectiveness of Jeryl Lynn-containing vaccine in Spanish children Castilla, Jesús
2009
27 Supplement 5 p. 2089-2093
5 p.
artikel
41 Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence Bonanni, Paolo
2009
27 Supplement 5 p. A46-A53
nvt p.
artikel
42 Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity Martelli, Paolo
2009
27 Supplement 5 p. 3788-3799
12 p.
artikel
43 Enhancement of the immune responses to vaccination against foot-and-mouth disease in mice by oral administration of an extract made from Rhizoma Atractylodis Macrocephalae (RAM) Li, Ruili
2009
27 Supplement 5 p. 2094-2098
5 p.
artikel
44 Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination Liang, Xiaofeng
2009
27 Supplement 5 p. 6550-6557
8 p.
artikel
45 Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: A case study in Tanzania Shim, Eunha
2009
27 Supplement 5 p. 7167-7172
6 p.
artikel
46 Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals Rupprecht, Charles E.
2009
27 Supplement 5 p. 7141-7148
8 p.
artikel
47 Evidence of effectiveness from a large county-wide school-based influenza immunization campaign Grijalva, Carlos G.
2009
27 Supplement 5 p. 2633-2636
4 p.
artikel
48 Genotyping of rotavirus isolates collected from children less than 5 years of age admitted for diarrhoea at the Yangon Children's Hospital, Myanmar Moe, Kyaw
2009
27 Supplement 5 p. F89-F92
nvt p.
artikel
49 Ginseng stem–leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice Song, Xiaoming
2009
27 Supplement 5 p. 51-55
5 p.
artikel
50 Hepatitis B vaccination failure in celiac disease: Is there a need to reassess current immunization strategies? Leonardi, S.
2009
27 Supplement 5 p. 6030-6033
4 p.
artikel
51 Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors Santra, Sampa
2009
27 Supplement 5 p. 5837-5845
9 p.
artikel
52 Hospital-based surveillance and molecular epidemiology of rotavirus infection in Taiwan, 2005–2007 Wu, F.T.
2009
27 Supplement 5 p. F50-F54
nvt p.
artikel
53 How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands Coupé, Veerle M.H.
2009
27 Supplement 5 p. 5111-5119
9 p.
artikel
54 Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5 Zhou, Mingguang
2009
27 Supplement 5 p. 5271-5277
7 p.
artikel
55 Ii-Key/HPV16 E7 hybrid peptide immunotherapy for HPV16+ cancers Xu, Minzhen
2009
27 Supplement 5 p. 4641-4647
7 p.
artikel
56 Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate Rojas-Caraballo, Jose
2009
27 Supplement 5 p. 2870-2876
7 p.
artikel
57 Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants Almeida, Volia De Carvalho
2009
27 Supplement 5 p. 3856-3861
6 p.
artikel
58 Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses Shao, Hsiao-Yun
2009
27 Supplement 5 p. 5460-5471
12 p.
artikel
59 Immunology of combining CRM197 conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants Lagos, Rosanna
2009
27 Supplement 5 p. 2299-2305
7 p.
artikel
60 Importance and challenges of accurately counting rotavirus deaths in China, 2002 Yee, Eileen L.
2009
27 Supplement 5 p. F46-F49
nvt p.
artikel
61 Incidence of intussusception among children 0–5 years of age in Thailand, 2001–2006 Khumjui, Chowalit
2009
27 Supplement 5 p. F116-F119
nvt p.
artikel
62 Influence of cytokine gene variations on immunization to childhood vaccines Yucesoy, Berran
2009
27 Supplement 5 p. 6991-6997
7 p.
artikel
63 Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination Ovsyannikova, Inna G.
2009
27 Supplement 5 p. 3359-3366
8 p.
artikel
64 Influence of the route of administration on immunomodulatory properties of bovine β-lactoglobulin-producing Lactobacillus casei Hazebrouck, S.
2009
27 Supplement 5 p. 5800-5805
6 p.
artikel
65 Influenza vaccination and mortality benefits: New insights, new opportunities Simonsen, Lone
2009
27 Supplement 5 p. 6300-6304
5 p.
artikel
66 In silico prediction and ex vivo evaluation of potential T-cell epitopes in glycoproteins 4 and 5 and nucleocapsid protein of genotype-I (European) of porcine reproductive and respiratory syndrome virus Díaz, Ivan
2009
27 Supplement 5 p. 5603-5611
9 p.
artikel
67 International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007 Tondella, M.L.
2009
27 Supplement 5 p. 803-814
12 p.
artikel
68 Internet-based monitoring of influenza-like illness in the general population: Experience of five influenza seasons in the Netherlands Friesema, I.H.M.
2009
27 Supplement 5 p. 6353-6357
5 p.
artikel
69 Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits Jansen, Angelique G.S.C.
2009
27 Supplement 5 p. 2394-2401
8 p.
artikel
70 Investigation of serum bactericidal activity in childhood and adolescence 3–6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine Sakou, Irine-Ikbale
2009
27 Supplement 5 p. 4408-4411
4 p.
artikel
71 In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB) Knowles, M. Kimberly
2009
27 Supplement 5 p. 2662-2668
7 p.
artikel
72 Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults de Voer, Richarda M.
2009
27 Supplement 5 p. 6974-6982
9 p.
artikel
73 Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine Hammitt, Laura L.
2009
27 Supplement 5 p. 7359-7366
8 p.
artikel
74 Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus Sasaki, Takashi
2009
27 Supplement 5 p. 5174-5177
4 p.
artikel
75 Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur® Adults Plentz, Annelie
2009
27 Supplement 5 p. 853-856
4 p.
artikel
76 Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur® Children Wittermann, Christoph
2009
27 Supplement 5 p. 1585-1588
4 p.
artikel
77 Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge Schell, John
2009
27 Supplement 5 p. 979-986
8 p.
artikel
78 Molecular epidemiology of rotavirus diarrhoea among children in Haiphong, Vietnam: The emergence of G3 rotavirus Cuong, Ngo Tuan
2009
27 Supplement 5 p. F75-F80
nvt p.
artikel
79 Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats Liu, G.X.
2009
27 Supplement 5 p. 2940-2947
8 p.
artikel
80 Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies Chianese-Bullock, Kimberly A.
2009
27 Supplement 5 p. 1764-1770
7 p.
artikel
81 Mumps resurgences in the United States: A historical perspective on unexpected elements Barskey, Albert E.
2009
27 Supplement 5 p. 6186-6195
10 p.
artikel
82 National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: Emergence of serotype 19A with high invasive potential Hsieh, Yu-Chia
2009
27 Supplement 5 p. 5513-5518
6 p.
artikel
83 Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity Gabitzsch, Elizabeth S.
2009
27 Supplement 5 p. 6394-6398
5 p.
artikel
84 Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting Jacobsen, Steven J.
2009
27 Supplement 5 p. 4656-4661
6 p.
artikel
85 Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine Henderson, Heather
2009
27 Supplement 5 p. 7194-7197
4 p.
artikel
86 Pediatric vaccination errors: Application of the “5 Rights” framework to a national error reporting database Bundy, David G.
2009
27 Supplement 5 p. 3890-3896
7 p.
artikel
87 Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells Huaman, Maria Cecilia
2009
27 Supplement 5 p. 5239-5246
8 p.
artikel
88 Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa Freeman, Esther E.
2009
27 Supplement 5 p. 940-946
7 p.
artikel
89 Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease Jacobsson, Susanne
2009
27 Supplement 5 p. 1579-1584
6 p.
artikel
90 Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy Dudareva, M.
2009
27 Supplement 5 p. 3501-3504
4 p.
artikel
91 Prevention of otitis media: Now a reality? Schuerman, Lode
2009
27 Supplement 5 p. 5748-5754
7 p.
artikel
92 Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis Holst, Johan
2009
27 Supplement 5 p. B3-B12
nvt p.
artikel
93 Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase Pavlova, Sophia P.
2009
27 Supplement 5 p. 773-785
13 p.
artikel
94 Protective immunization with homologous and heterologous antigens against Helicobacter suis challenge in a mouse model Flahou, Bram
2009
27 Supplement 5 p. 1416-1421
6 p.
artikel
95 Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines Franka, Richard
2009
27 Supplement 5 p. 7149-7155
7 p.
artikel
96 Reasons for non-adherence to vaccination at mother and child care clinics (MCCs) in Lambaréné, Gabon Schwarz, Norbert G.
2009
27 Supplement 5 p. 5371-5375
5 p.
artikel
97 Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic Simani, Omphile E.
2009
27 Supplement 5 p. 146-151
6 p.
artikel
98 Regulatory oversight of clinical trials in Africa: Progress over the past 5 years Maïga, Diadié
2009
27 Supplement 5 p. 7249-7252
4 p.
artikel
99 Risk of lymphoma and leukaemia after bacille Calmette-Guérin and smallpox vaccination: A Danish case-cohort study Villumsen, Marie
2009
27 Supplement 5 p. 6950-6958
9 p.
artikel
100 Rotavirus diarrhoea among children aged less than 5 years at Mahosot Hospital, Vientiane, Lao PDR Aloun, Douangdao Souk
2009
27 Supplement 5 p. F85-F88
nvt p.
artikel
101 Rotavirus infection in hospitalized children and estimates of disease burden in Kyrgyzstan, 2005–2007 Flem, Elmira T.
2009
27 Supplement 5 p. F35-F39
nvt p.
artikel
102 Safety and immunogenicity of sequential pneumococcal immunization in preschool asthmatics Rose, Markus A.
2009
27 Supplement 5 p. 5259-5264
6 p.
artikel
103 Safety experience with heptavalent pneumococcal CRM197-conjugate vaccine (Prevenar®) since vaccine introduction Center, Kimberly J.
2009
27 Supplement 5 p. 3281-3284
4 p.
artikel
104 Secreted proteins of Neisseria meningitidis protect mice against infection Li, Yanwen
2009
27 Supplement 5 p. 2320-2325
6 p.
artikel
105 Sialivac: An intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry Worrall, E.E.
2009
27 Supplement 5 p. 4161-4168
8 p.
artikel
106 SIP 5: Social distancing during a pandemic Not sexy, but sometimes effective: Social distancing and Non-Pharmaceutical Interventions 2009
27 Supplement 5 p. 6383-6386
4 p.
artikel
107 sopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria Nagarajan, Arvindhan G.
2009
27 Supplement 5 p. 2804-2811
8 p.
artikel
108 Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin Song, Langzhou
2009
27 Supplement 5 p. 5875-5884
10 p.
artikel
109 Surveillance of rotavirus in a rural diarrhoea treatment centre in Bangladesh, 2000–2006 Zaman, K.
2009
27 Supplement 5 p. F31-F34
nvt p.
artikel
110 The burden of hospitalised rotavirus infections in Fiji Jenney, Adam
2009
27 Supplement 5 p. F108-F111
nvt p.
artikel
111 The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix Maciag, Paulo Cesar
2009
27 Supplement 5 p. 3975-3983
9 p.
artikel
112 The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap Heldens, J.G.M.
2009
27 Supplement 5 p. 5530-5537
8 p.
artikel
113 The immunogenicity of viral haemorragic septicaemia rhabdovirus (VHSV) DNA vaccines can depend on plasmid regulatory sequences Chico, V.
2009
27 Supplement 5 p. 1938-1948
11 p.
artikel
114 The protective mechanisms induced by a fish rhabdovirus DNA vaccine depend on temperature Lorenzen, E.
2009
27 Supplement 5 p. 3870-3880
11 p.
artikel
115 Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populations Snedecor, Sonya J.
2009
27 Supplement 5 p. 4694-4703
10 p.
artikel
116 Treatment with demethylating agent, 5-aza-2′-deoxycytidine enhances therapeutic HPV DNA vaccine potency Lu, Dan
2009
27 Supplement 5 p. 4363-4369
7 p.
artikel
117 Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy Durando, Paolo
2009
27 Supplement 5 p. 3459-3462
4 p.
artikel
118 Use of intravenous fluids in Hong Kong children hospitalised for diarrhoea and relationship to severity and aetiology Chow, C.M.
2009
27 Supplement 5 p. F55-F60
nvt p.
artikel
119 Use of MDCK cells for production of live attenuated influenza vaccine Liu, Jonathan
2009
27 Supplement 5 p. 6460-6463
4 p.
artikel
120 Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen Mealey, Robert H.
2009
27 Supplement 5 p. 2453-2468
16 p.
artikel
                             120 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland